Scientists track Drug's journey through the body
NCT ID NCT07301723
Summary
This early-stage study aims to measure how much of an oral dose of the experimental drug cenerimod actually gets into a person's bloodstream. Six healthy male volunteers will take a cenerimod pill and later receive a tiny, traceable intravenous dose to allow precise measurement. The main goal is to gather basic data on how the body processes the drug and to check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharmaceutical Research Associates Group B.V.
Groningen, 9728, Netherlands
Conditions
Explore the condition pages connected to this study.